WO2021104095A1 - 一种植入式医疗器件及其制造方法 - Google Patents
一种植入式医疗器件及其制造方法 Download PDFInfo
- Publication number
- WO2021104095A1 WO2021104095A1 PCT/CN2020/129206 CN2020129206W WO2021104095A1 WO 2021104095 A1 WO2021104095 A1 WO 2021104095A1 CN 2020129206 W CN2020129206 W CN 2020129206W WO 2021104095 A1 WO2021104095 A1 WO 2021104095A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chip
- anisotropic conductive
- electrode
- pads
- conductive material
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 29
- 239000004020 conductor Substances 0.000 claims abstract description 63
- 230000000638 stimulation Effects 0.000 claims abstract description 48
- 238000007906 compression Methods 0.000 claims abstract description 8
- 229910000679 solder Inorganic materials 0.000 claims description 33
- 238000005538 encapsulation Methods 0.000 claims description 23
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 230000006835 compression Effects 0.000 claims description 7
- 238000003825 pressing Methods 0.000 claims description 3
- 238000007650 screen-printing Methods 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000003466 welding Methods 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims 1
- 238000012546 transfer Methods 0.000 abstract description 3
- 239000010410 layer Substances 0.000 description 38
- 239000002245 particle Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 12
- 238000010586 diagram Methods 0.000 description 9
- 239000010931 gold Substances 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 229910052758 niobium Inorganic materials 0.000 description 2
- 239000010955 niobium Substances 0.000 description 2
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000005476 soldering Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000012792 core layer Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005566 electron beam evaporation Methods 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 238000009422 external insulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000001755 magnetron sputter deposition Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36036—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the outer, middle or inner ear
- A61N1/36038—Cochlear stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36046—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36125—Details of circuitry or electric components
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
- H01L21/50—Assembly of semiconductor devices using processes or apparatus not provided for in a single one of the subgroups H01L21/06 - H01L21/326, e.g. sealing of a cap to a base of a container
- H01L21/56—Encapsulations, e.g. encapsulation layers, coatings
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/48—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor
- H01L23/488—Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor consisting of soldered or bonded constructions
Definitions
- the invention belongs to the technical field of medical devices, and specifically relates to an implantable medical device and a manufacturing method thereof.
- Implantable medical devices are widely used because they can restore part of the patient's body functions through functional repair methods, achieve the effects of curing diseases and prolonging life.
- people have higher and higher requirements for implanted devices, and they have begun to develop in the direction of intelligence, miniaturization and multi-channel.
- it is currently more difficult to produce high-density chips and high-density implantable electrodes, and the connection between the two is even more difficult.
- high-density chips and high-density implantable electrodes The connection process is still blank.
- the existing low-density chip and the low-density electrode are connected in the following way: first connect the chip, electronic components and the PCB board, and connect the formed integrated circuit board and the substrate connected with the flexible electrode by reflow soldering technology. , And then realize the electrical connection between the chip and the electrode. That is, there is no direct connection between the chip and the electrode, and an integrated circuit board is required for switching.
- the high-density flexible electrodes of implantable medical devices are thinner, have more stimulation channels (>1000 channels), and the pad spacing is small. If the existing reflow soldering technology is used to directly connect high-density chips and high-density implanted electrodes , It will cause problems such as more false welding, lower conductivity, more cracks, and lower strength.
- the present invention provides a method for manufacturing an implantable medical device, which is particularly suitable for connecting high-density chips and high-density implanted electrodes, without the need for switching of integrated circuit boards.
- the connection method has simple operation and high connection efficiency, and the product after connection has extremely high conduction rate and high connection strength.
- the present invention provides a method for manufacturing an implantable medical device, including:
- the electrode includes a stimulation terminal and a connection terminal that are arranged oppositely.
- the stimulation terminal includes N stimulation terminal pads, the connection terminal includes N connection terminal pads, and the N stimulation terminals are welded.
- the disk and the N connection terminal pads are connected in a one-to-one correspondence through wires, and N is an integer ⁇ 1;
- a chip is provided, the chip has a first surface and a second surface which are arranged oppositely, and N chip pads arranged at intervals are provided on the first surface;
- An anisotropic conductive material is provided on the die pad; the electrode is attached to the chip provided with the anisotropic conductive material, so that the connection terminal pad and the die pad are one-to-one quasi;
- the bonded electrode and the chip are thermocompressed, wherein, during the thermocompression bonding, pressure is applied to the second surface of the chip and the side of the connecting end away from the chip; the thermocompression After bonding, the chip pad is connected to the connection terminal pad through an anisotropic conductive material, and in the energized state, the chip pad and the connection terminal pad are only along the vertical direction of the first surface The direction of conduction.
- the thickness of the electrode is 10-50 ⁇ m.
- anisotropic conductive material is selected from anisotropic conductive adhesive ACA (Anisotropic Conductive Adhesive), anisotropic conductive film ACF (Anisotropic Conductive film) and anisotropic conductive paste ACP (Anisotropic conductive One or more of paste).
- the arrangement of the anisotropic conductive material includes screen printing, coating or pasting.
- the orthographic projections of the chip pads and the gaps between them on the electrodes all fall within the area covered by the anisotropic conductive material.
- the setting thickness of the anisotropic conductive material is 20-50 ⁇ m.
- the bonding of the electrode and the chip is performed under an inverted microscope or an upright microscope.
- thermocompression bonding is 120-180°C; the pressure applied during the thermocompression bonding is 10-1000g.
- the holding time of the thermocompression bonding is 1-20s.
- the shear strength between the chip and the electrode is 200-800 g.
- solder balls are also planted on each of the chip pads.
- the material of the solder ball is tin, gold or an alloy thereof; the size of the solder ball does not exceed the size of the connecting terminal pad. Further preferably, the size of the solder ball is 0.04-0.2 mm.
- the manufacturing method further includes: manufacturing a biocompatible packaging layer, and the chip, the electrode and the anisotropic conductive material are located in the accommodating layer of the packaging layer. In the space, and the stimulation terminal pad is exposed from the encapsulation layer.
- the roughness Ra of the encapsulation layer is 0.1-0.2; the thickness of the encapsulation layer is 0.1-0.5 mm.
- the present invention also provides an implantable medical device, including implantable electrodes and a chip; the electrodes include oppositely arranged stimulation terminals and connecting terminals, the stimulation terminals include N stimulation terminal pads, so
- the connection terminal includes N connection terminal pads; the N stimulation terminal pads and the N connection terminal pads are connected in a one-to-one correspondence with wires, and N is an integer ⁇ 1000; on the first surface of the chip N chip pads are arranged at intervals;
- An anisotropic conductive material is connected between the chip pad and the connecting terminal pad, and in the energized state, the chip pad and the connecting terminal pad are only along a direction perpendicular to the first surface Conduction.
- the implantable medical device further includes an encapsulation layer with biocompatibility, the chip, the electrode, and the anisotropic conductive material are located in the accommodating space of the encapsulation layer, and the stimulation The terminal pad is exposed from the encapsulation layer.
- the thickness of the anisotropic conductive material is 20-50 ⁇ m.
- the connection between the chip and the implanted electrode is realized by an anisotropic conductive material, and the conduction is only in the longitudinal direction in the energized state, without the need for an integrated circuit board
- the manufacturing method is simple to operate, does not require expensive raw materials and complicated equipment, and can significantly improve the connection efficiency of the chip and the implanted electrode.
- the chip and the electrode have extremely high conduction rate and high connection strength, which can avoid the problems of virtual welding and cracks caused by the use of integrated circuit board transfer in the prior art.
- the preparation method is particularly suitable for the connection of high-density chips and high-density implanted electrodes.
- the implantable medical device provided by the second aspect of the present invention, there is no integrated circuit board, and the structure is simple.
- the chip and the electrode are connected through anisotropic conductive material, and the conduction in the longitudinal direction in the energized state.
- the conduction rate is extremely high, the connection strength is high, and there are no problems such as virtual welding and cracking.
- FIG. 1 is a process flow diagram of a manufacturing method of an implantable medical device in an embodiment of the present invention
- FIG. 2 is a schematic diagram of the structure of an implantable electrode in an embodiment of the present invention.
- FIG. 3 is a schematic diagram of the structure of a chip in an embodiment of the present invention.
- FIG. 4 is a schematic diagram of the structure of the chip in FIG. 3 after being aligned with the implanted electrode of FIG. 2 with solder balls and anisotropic conductive materials sequentially arranged on the chip pads;
- FIG. 5 is a schematic diagram of the conductive particles (a) of the anisotropic conductive material in the present invention and the structure (b) of the anisotropic conductive material in the present invention;
- FIG. 6 is a schematic diagram of the structure of the implantable medical device in FIG. 4 after being coated with an encapsulation layer;
- FIG. 7 is a process flow diagram of a manufacturing method of an implantable medical device in another embodiment of the present invention.
- Fig. 8 is a schematic structural diagram of an implantable medical device manufactured by the method of Fig. 7.
- Implantable electrode-1 stimulation terminal pad-11, connection terminal pad-12, chip-2, chip pad-21, solder ball-22, anisotropic conductive material 3, encapsulation layer-4.
- FIG. 1 is a flowchart of a manufacturing method of an implantable medical device disclosed in an embodiment of the present invention. This method is particularly suitable for the manufacture of high-density implantable medical devices.
- the manufacturing method of the implantable medical device described in this embodiment includes steps S101, S102, S103, and S104.
- an implantable electrode 1 is provided.
- the electrode 1 includes a stimulation terminal 101 and a connection terminal 102 arranged oppositely.
- the stimulation terminal 101 includes N stimulation terminal pads 11, and the connection terminal 102 includes N connection terminal pads 12 ,
- the N stimulation terminal pads 11 and the N connection terminal pads 12 are connected in a one-to-one correspondence through the wire 13, and N is an integer ⁇ 1.
- connection terminal 102 of the implantable electrode 1 is mainly connected to a chip, electronic components, etc., for the purpose of transmitting the stimulation current emitted by the chip or the like to the electrode 1.
- the stimulating terminal 101 is used to stimulate human tissues or organs, and can be attached to human tissues, such as cerebral cortex, retinal cortex, and cochlear cortex, so that when a stimulating current passes through, it can have a functional stimulating effect on the human body.
- the stimulation terminal pads 11 of the stimulation terminal 101 correspond to the connection terminal pads 12 of the connection terminal 102 in a one-to-one correspondence, and are correspondingly connected by wires, and the number of wires is also N.
- the number of N represents the number of channels of electrode 1.
- N when N is 1500, it means that the electrode 1 has 1500 stimulation channels.
- N when the electrode 1 is a high-density implantable electrode 1, N may be an integer ⁇ 1000. Preferably it is an integer ⁇ 2000.
- the distribution density of the stimulation terminal pads 11 of the high-density implantable electrode 1 may be 10-50 pieces•mm -2 .
- the thickness of the electrode 1 is 10-50 ⁇ m.
- the multiple pads of the stimulation terminal 101 are respectively denoted as A, B, C, D,...Z
- the multiple pads of the connecting terminal 102 are respectively denoted as A', B', C ', D',...Z', where A and A'pads are electrically connected, B and B'pads are electrically connected, and so on.
- the material of the stimulation terminal pad 11 and the connection terminal pad 12 is a biocompatible conductive material, which can be independently selected from one or more of platinum, titanium, iridium, palladium, niobium, tantalum and their alloys; but Gold cannot be used, because long-term implantation of gold will cause electron migration, which significantly shortens the life of the implanted device. It is preferable to use high-stability pure platinum bonding pads.
- the production technology of the stimulation terminal pad 11 and the connection terminal pad 12 generally adopts sputtering technology (magnetron sputtering, electron beam evaporation), electroplating, chemical plating, or the like.
- the size of the stimulation terminal pad 11 and the connection terminal pad 12 are designed according to the size of the implantable medical device.
- the connection terminal pad 12 (or the stimulation terminal pad 11) has a thickness of 50-2000 nm and a diameter of 30 -300 ⁇ m, the pitch is 80-600 ⁇ m.
- the stimulation terminal pad 11 and the connection terminal pad 12 are located on the same surface of the electrode 1 (that is, arranged in the same direction), and the surface subsequently faces the first surface 201 of the chip 2. Of course, in other embodiments, they can also be located on two opposite surfaces of the electrode 1.
- the material of the wire 13 may be the same as or different from that of the stimulation terminal pad 11 and the connection terminal pad 12. It is independently selected from one of gold, platinum, titanium, iridium, palladium, niobium, tantalum and their alloys. Many kinds.
- a chip 2 is provided.
- the chip 2 has a first surface 201 and a second surface 202 opposed to each other.
- N chip pads 21 are arranged on the first surface 201 at intervals, and each chip pad 21 is planted with Solder balls 22.
- the N chip pads 21 are in a one-to-one correspondence with the aforementioned N connection terminal pads 12, and their positions and arrangements are the same.
- the first surface 201 here is also the side where the subsequent chip 2 and the electrode 1 are to be connected.
- the chip 2 is generally a flip chip, that is, the chip pads 21 are all located on the lower surface of the chip (ie, the side 201 to be connected to the electrode 1). There are only chip pads 21 on the first surface 201, and no pads for electronic components or the like. Of course, in other embodiments of the present invention, the chip 2 may also be a formal chip.
- the chip 2 is generally rectangular.
- the chip 2 is a rectangle or a square with a side length of 6-15 mm.
- Chip 2 is too small to accommodate more than 1,000 chip pads, too large will cause difficulty in implanting the human body, and will cause greater harm to the human body.
- the material of the die pad 21 is generally one or more of copper, aluminum, tin, silver, and alloys thereof.
- the size of the die pad 21 is not larger than the size of the connection terminal pad 12.
- the chip 2 Before the chip 2 is connected to the implantable electrode 1, the chip 2 can be implanted.
- the implanted solder balls 22 can facilitate the application of pressure to the chip at a certain temperature in the later stage, and can better crush the outer insulating layer of the conductive particles in the anisotropic conductive material 3.
- the solder ball 22 may be tin, gold or an alloy thereof; the size of the solder ball 22 is not larger than the size of the die pad 21. Naturally, the size of the solder ball 22 is also not larger than the size of the connection terminal pad 12. More preferably, the size of the solder ball 22 is 0.04-0.2 mm.
- the anisotropic conductive material 3 is arranged on the die pad 21; the electrode 1 is attached to the chip 2 provided with the anisotropic conductive material 3, so that the connection terminal pad 12 and the die pad 21 are aligned one by one .
- the aligned product is shown in Figure 4.
- the anisotropic conductive material 3 may be solid (such as a film) or semi-solid (such as a paste).
- the semi-solid anisotropic conductive adhesive ACA (Anisotropic Conductive Adhesive) and anisotropic conductive paste ACP (Anisotropic conductive paste Paste) can be printed on the solder balls 22 by screen printing or manually coated on the solder balls 22, while the anisotropic conductive film ACF (Anisotropic Conductive film) directly cut into a suitable size and manually paste it on the solder ball 22.
- the anisotropic conductive material 3 is an anisotropic conductive film ACF.
- the application of ACF is more convenient, and its setting thickness can be 20-50 ⁇ m.
- the setting direction is parallel to the first surface 201 of the chip 2.
- the coverage area of the anisotropic conductive material 3 on the chip 2 needs to be greater than or equal to the area of the chip pad 21 (when there are solder balls on the chip pad 21) , Also greater than or equal to the area of the solder ball 22).
- the orthographic projection of the die pad 21 and the gap between the die pad 21 (the solder ball 22 and the gap therebetween) on the electrode 1 all fall within the area covered by the anisotropic conductive material 3.
- the anisotropic conductive material 3 also covers the connection terminal pad 12 of the electrode 1.
- the projection contour line of the anisotropic conductive material 3 on the electrode 1 is 1-5 mm from the projection contour line of the N connection terminal pads 12 on the electrode 1.
- the bonding of the electrode 1 and the chip 2 is performed under an inverted microscope or an upright microscope. Since the implanted electrode 1 is of high density, its thickness is relatively thin (10-50 ⁇ m thick). When the electrode 1 is attached to the chip 2, the light emitted by the inverted microscope or the upright microscope used can pass through the electrode 1. And the anisotropic conductive material 3 can see the die pad 21, so that the connection terminal pad 12 of the electrode 1 and the die pad 21 can be aligned one by one (as shown in Figure 4) to ensure the final Implantable medical devices can work normally.
- the anisotropic conductive material 3 used in the present invention is a connecting material with the three characteristics of adhesion, conductivity and insulation. It includes a binder, and conductive particles dispersed in the binder. In the case of heat and pressure, it can conduct in the vertical direction (Z direction, longitudinal) and insulate in the horizontal direction (X, Y direction).
- the difference in the binder in the anisotropic conductive material 3 may result in a different shape of the anisotropic conductive material 3 (such as a paste shape, a film shape).
- the binder is usually sensitive to temperature and pressure, and can be a thermoplastic tacky resin or a thermosetting tacky resin. It is preferable to use a thermoplastic resin with a low curing temperature so that the connection can be achieved at a lower temperature.
- Conductive particles are usually spherical and have various structures depending on the usage.
- the conductive particles may include a resin core layer, a conductive layer, and an insulating layer in sequence along the center of the sphere (as shown in Fig. 5(a)).
- the conductive layer of the conductive particle may be a single Ni layer, Ag layer, or Au layer, or may include an Au layer and a Ni layer arranged in sequence along the spherical center of the conductive particle.
- an anisotropic conductive material 3 with a large number of conductive particles, uniformity, and low resistance.
- the conductivity of the anisotropic conductive material 3 needs to meet the requirement that the longitudinal (Z-axis direction) conduction resistance during conduction should be sufficiently low, generally lower than 1-10 ⁇ ; and the transverse (X-axis, Y-axis direction) insulation that needs to be insulated The resistance must be greater than 100-10000M ⁇ .
- S104 Perform thermocompression bonding of the bonded electrode 1 and the chip 2, where, during the thermocompression bonding, pressure is applied to the second surface 202 of the chip 2 and the connecting end 102 of the electrode 1 facing away from the chip 2 (apply The direction of the pressure is shown by the arrow in Figure 4).
- the solder ball 22 is connected to the connection terminal pad 12 through the anisotropic conductive material 3, and in the energized state, the solder ball 22 is connected to the connection terminal
- the pad 12 is only conductive in the direction perpendicular to the first surface 201 (ie, the Z axis).
- the electrode 1 and the chip 2 are connected with the anisotropic conductive material 3 by thermocompression bonding (heating, pressing).
- the conductive particles in the anisotropic conductive material 3 are used to connect the solder balls 22 and the connecting terminal pads 12 vertically, while avoiding the conduction and short-circuit between the adjacent solder balls 22 and the connecting terminal pads 12, and finally
- the ideal state where the die pad 21 and the connection terminal pad 12 of the electrode 1 are connected and conducted in the vertical direction, and are firmly connected in other directions but insulated from each other is perfectly realized.
- the anisotropic conductive material 3 is an insulator under normal conditions.
- pressure is applied to its longitudinal direction (Z-axis direction) at a certain temperature, due to the electrical conduction between the solder ball 22 and the connecting terminal pad 12 in the longitudinal direction
- the pressure on the particles is relatively high (this part is due to the bumps of the solder balls 22 and the connecting terminal pad 12, so it is stronger than the pressure of the conductive particles in the gap corresponding to the connecting terminal pad 12), and the external insulation of this part of the conductive particle
- the layer will be broken, so that the conductive layer of the conductive particles and the corresponding solder balls 22 and the connection terminal pads 12 are in contact with each other to realize the longitudinal conduction between the chip 2 and the electrode 1, and the gap corresponding to the chip pad 21 is anisotropic
- the conductive particles of the conductive material 3 are complete, as shown in Figure 5(b); the insulating layer of the conductive particles in the other directions (X-axis and Y-axis) is not crushed, and the anis
- the temperature of the hot pressing is 120-180°C; the applied pressure is 10-1000 g. If the predetermined temperature is too high, the chip 2 and the electrode 1 will be burned, and if it is too low, the adhesive in the anisotropic conductive material 3 will not be cured, and the chip 2 and the electrode 1 will not be firmly connected. If the pressure used for hot pressing is too large, it will easily crush the chip 2; if the pressure is too small, the outer insulating layer of conductive particles in the anisotropic conductive material 3 cannot be crushed, and the chip 2 and the electrode 1 cannot be vertically aligned. The electrical conduction.
- the holding time of the thermocompression bonding is 1-20 s. For example, it is 1-10s, 5-20s, or 5-10s. The holding time of the thermocompression bonding can be adjusted according to the size of the chip 2.
- the heat source is removed, the adhesive in the anisotropic conductive material 3 is cured, and the chip 2 and the electrode 1 are firmly connected together.
- the shear strength between the chip 2 and the electrode 1 is 200-800 g.
- the resistance of the conduction part between the chip 2 and the connection terminal pad 12 of the electrode 1 is generally lower than 1-10 ⁇ , which achieves good conduction in the longitudinal direction (Z-axis direction); and the lateral resistance It needs to be greater than 100-10000M ⁇ to make the transverse direction (X-axis and Y-axis directions) completely insulated.
- the manufacturing method may further include step S105.
- S105 Making a biocompatible packaging layer 4, where the chip 2, the electrode 1 and the anisotropic conductive material 3 are located in the accommodating space of the packaging layer 4, and the stimulation terminal pad 11 is exposed from the packaging layer 4.
- the formed implantable medical device is shown in Figure 6.
- the encapsulation layer 4 wraps the structure formed by the chip 2 and the electrode 1 after thermal compression (for example, covering the second surface and the periphery of the chip 2, the periphery of the chip pad 21 and the solder ball 22, the anisotropic conductive material 3
- the periphery, the electrode 1 is away from the outer surface and periphery of the chip, etc.), but the stimulation terminal pad 11 is not covered.
- the gap between the stimulation terminal pads 11 may not be covered by the encapsulation layer 4 (as shown in FIG. 6).
- the encapsulation layer 4 is continuously coated.
- the material of the encapsulation layer 4 is a biocompatible material, which can be implantable silicone or resin.
- the presence of the encapsulation layer 4 can ensure that the obtained implantable medical device can gently contact the human body, and can also prevent the device from corroding electrodes, chips, etc. due to long-term contact with the human body.
- the surface of the encapsulation layer 4 must be relatively smooth to avoid harm to the human body.
- the roughness Ra of the encapsulation layer 4 is 0.1-0.2.
- the encapsulation layer 4 can be formed by injection molding, die casting, or the like.
- the thickness of the encapsulation layer 4 is 0.1-0.5 mm.
- the connection between the chip and the implanted electrode and the conduction only in the longitudinal direction are realized by the anisotropic conductive material, and the switching of the integrated circuit board is not required.
- the manufacturing method is simple to operate, does not require expensive raw materials and complex equipment, and can significantly improve the connection efficiency of the chip and the electrode.
- the chip and the electrode have extremely high conduction rate and high connection strength, which can avoid the problems of virtual welding and cracks caused by the use of integrated circuit board transfer in the prior art.
- the preparation method is particularly suitable for the connection of high-density chips and high-density implanted electrodes.
- the embodiment of the present invention also provides an implantable medical device manufactured by the above-mentioned method.
- an implantable medical device manufactured by the above-mentioned method for a schematic diagram of the structure, please refer to FIG. 2 and FIG. 6 together.
- the implantable medical device includes an implanted electrode 1 and a chip 2.
- the electrode 1 includes a stimulation terminal 101 and a connection terminal 102 arranged oppositely, the stimulation terminal 101 includes N stimulation terminal pads 11, the connection terminal 102 includes N connection terminal pads 12, N stimulation terminal pads 11 and N
- the connection terminal pads 12 are connected in a one-to-one correspondence through the wires 13, and N is an integer ⁇ 1.
- N chip pads 21 are arranged on the first surface 201 of the chip 2 at intervals, and solder balls 22 are planted on each chip pad 21; an anisotropic conductive material 3 is connected between the solder balls 22 and the connecting terminal pads 12 , And in the energized state, the solder ball 22 and the connection terminal pad 12 are only conducted in a direction perpendicular to the first surface 201.
- the implantable medical device further includes an encapsulation layer 4, the chip 2, the electrode 1 and the anisotropic conductive material 3 are all located in the accommodating space of the encapsulation layer, but the stimulation terminal pad of the electrode 1 is not covered.
- the implanted medical device provided by the embodiment of the present invention, there is no integrated circuit board, and the chip 2 and the electrode 1 are connected through the anisotropic conductive material 3 and conduction in the longitudinal direction.
- the conduction rate of the two is extremely high and the connection is very high.
- the strength is large, and there are no problems such as virtual welding and cracking.
- Another embodiment of the present invention also provides a manufacturing method of an implantable medical device, the process flow of which is shown in FIG. 7. Including steps S201, S202, S203 and S204.
- the difference between this embodiment and the previous embodiment is that no solder balls are provided on the die pad 21. I will not repeat the steps here. After applying pressure at a predetermined temperature, the die pad 21 is directly connected to the connecting terminal pad 12 through the anisotropic conductive material 3, and in the energized state, the die pad 21 and the connecting terminal pad 12 are only along the first vertical direction. The direction of the surface 201 is conductive.
- step S205 of making the encapsulation layer 4 with biocompatibility after the step S204.
- the final implantable medical device is shown in Figure 8.
- FIG. 8 is similar to FIG. 6, except that no solder balls 22 are provided on the die pad 21.
- the preparation method of this embodiment also does not require the switching of the integrated circuit board, the operation is simple, and the connection efficiency of the chip 2 and the electrode 1 can be significantly improved without the use of expensive raw materials and complicated equipment.
- the preparation method is particularly suitable for the connection of high-density chips and high-density implanted electrodes.
- the conductivity of the chip 2 and the electrode 1 is extremely high, and the connection strength is high, which can avoid the problems of virtual welding and cracks caused by the use of integrated circuit board switching in the prior art.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Power Engineering (AREA)
- Otolaryngology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Manufacturing & Machinery (AREA)
- Ophthalmology & Optometry (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims (10)
- 一种植入式医疗器件的制造方法,其特征在于,包括:提供植入式电极,所述电极包括相对设置的刺激端和连接端,所述刺激端包括N个刺激端焊盘,所述连接端包括N个连接端焊盘;所述N个刺激端焊盘与所述N个连接端焊盘通过导线一一对应连接,N为≥1的整数;提供芯片,所述芯片具有相对设置的第一表面和第二表面,所述第一表面上间隔设置N个芯片焊盘;在所述芯片焊盘上设置各向异性导电材料;将所述电极与设置有所述各向异性导电材料的芯片相贴合,使所述连接端焊盘和所述芯片焊盘一一对准;对贴合后的所述电极和芯片进行热压合,其中,所述热压合时,朝所述芯片的第二表面和所述连接端背离所述芯片的一面施加压力;在所述热压合后,所述芯片焊盘通过各向异性导电材料与所述连接端焊盘相连接,且在通电状态下,所述芯片焊盘与所述连接端焊盘仅沿垂直所述第一表面的方向导通。
- 如权利要求1所述的制造方法,其特征在于,所述各向异性导电材料选自各向异性导电胶、各向异性导电薄膜和各向异性导电浆料中的一种或多种;所述各向异性导电材料的设置方式包括丝网印刷、涂布或粘贴。
- 如权利要求2所述的制造方法,其特征在于,所述芯片焊盘及其之间的间隙在所述电极上的正投影均落入所述各向异性导电材料所覆盖的区域内。
- 如权利要求1所述的制造方法,其特征在于,所述各向异性导电材料的设置厚度为20-50μm。
- 如权利要求5所述的制造方法,其特征在于,所述热压合时的温度为120-180℃;所述热压合时所施加的压力为10-1000g。
- 如权利要求1-5任一项所述的制造方法,其特征在于,每个所述芯片焊盘上还植有焊球。
- 如权利要求1-6任一项所述的制造方法,其特征在于,在所述热压合之后,所述制造方法还包括:制作具有生物相容性的封装层;其中,所述芯片、所述电极与所述各向异性导电材料位于所述封装层的容置空间内,且所述刺激端焊盘从所述封装层中露出。
- 一种植入式医疗器件,其特征在于,包括植入式电极与芯片;所述电极包括相对设置的刺激端和连接端,所述刺激端包括N个刺激端焊盘,所述连接端包括N个连接端焊盘;所述N个刺激端焊盘与所述N个连接端焊盘通过导线一一对应连接,N为≥1的整数;所述芯片具有相对设置的第一表面和第二表面,所述第一表面上间隔设置有N个芯片焊盘;所述芯片焊盘和所述连接端焊盘之间连接有各向异性导电材料,且在通电状态下,所述芯片焊盘和所述连接端焊盘仅沿垂直所述第一表面的方向导通。
- 如权利要求8所述的植入式医疗器件,其特征在于,还包括具有生物相容性的封装层,所述芯片、所述电极与所述各向异性导电材料位于所述封装层的容置空间内,且所述刺激端焊盘从所述封装层中露出。
- 如权利要求9所述的植入式医疗器件,其特征在于,所述各向异性导电材料厚度为20-50μm。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911219294.6A CN111111006A (zh) | 2019-11-29 | 2019-11-29 | 一种植入式医疗器件及其制造方法 |
CN201911219294.6 | 2019-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021104095A1 true WO2021104095A1 (zh) | 2021-06-03 |
Family
ID=70497184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/129206 WO2021104095A1 (zh) | 2019-11-29 | 2020-11-17 | 一种植入式医疗器件及其制造方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111111006A (zh) |
WO (1) | WO2021104095A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111111006A (zh) * | 2019-11-29 | 2020-05-08 | 深圳先进技术研究院 | 一种植入式医疗器件及其制造方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104650789A (zh) * | 2015-02-11 | 2015-05-27 | 武汉轻工大学 | 一种各向异性导电胶及封装方法 |
CN107583191A (zh) * | 2016-07-07 | 2018-01-16 | 徐文敏 | 一种神经刺激器装置 |
CN109821149A (zh) * | 2019-03-04 | 2019-05-31 | 微智医疗器械有限公司 | 视网膜假体、植入装置及柔性电缆 |
CN109999343A (zh) * | 2019-03-30 | 2019-07-12 | 深圳硅基仿生科技有限公司 | 植入式器件的电子封装体及视网膜刺激器 |
CN111111006A (zh) * | 2019-11-29 | 2020-05-08 | 深圳先进技术研究院 | 一种植入式医疗器件及其制造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000332052A (ja) * | 1999-05-18 | 2000-11-30 | Hitachi Ltd | 半導体装置の製造方法および半導体装置 |
US7211103B2 (en) * | 2002-04-11 | 2007-05-01 | Second Sight Medical Products, Inc. | Biocompatible bonding method and electronics package suitable for implantation |
JP3755824B2 (ja) * | 2003-03-04 | 2006-03-15 | 株式会社らいふ | 複数電極接着用の電子部品とその実装方法 |
KR20180024029A (ko) * | 2010-04-22 | 2018-03-07 | 세키스이가가쿠 고교가부시키가이샤 | 이방성 도전 재료 및 접속 구조체 |
CN107982637A (zh) * | 2017-12-15 | 2018-05-04 | 深圳先进技术研究院 | 植入式医疗器件的制造方法、植入式医疗器件及对准装置 |
-
2019
- 2019-11-29 CN CN201911219294.6A patent/CN111111006A/zh active Pending
-
2020
- 2020-11-17 WO PCT/CN2020/129206 patent/WO2021104095A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104650789A (zh) * | 2015-02-11 | 2015-05-27 | 武汉轻工大学 | 一种各向异性导电胶及封装方法 |
CN107583191A (zh) * | 2016-07-07 | 2018-01-16 | 徐文敏 | 一种神经刺激器装置 |
CN109821149A (zh) * | 2019-03-04 | 2019-05-31 | 微智医疗器械有限公司 | 视网膜假体、植入装置及柔性电缆 |
CN109999343A (zh) * | 2019-03-30 | 2019-07-12 | 深圳硅基仿生科技有限公司 | 植入式器件的电子封装体及视网膜刺激器 |
CN111111006A (zh) * | 2019-11-29 | 2020-05-08 | 深圳先进技术研究院 | 一种植入式医疗器件及其制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111111006A (zh) | 2020-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10159845B2 (en) | Biocompatible bonding method and electronics package suitable for implantation | |
JP3420917B2 (ja) | 半導体装置 | |
KR100290993B1 (ko) | 반도체장치,반도체탑재용배선기판및반도체장치의제조방법 | |
US6544428B1 (en) | Method for producing a multi-layer circuit board using anisotropic electro-conductive adhesive layer | |
TW200303588A (en) | Semiconductor device and its manufacturing method | |
JPH02230610A (ja) | 電気的装置 | |
TW200426903A (en) | Semiconductor device and production method therefor | |
WO2016114293A1 (ja) | バンプ形成用フィルム、半導体装置及びその製造方法、並びに接続構造体 | |
WO2021104095A1 (zh) | 一种植入式医疗器件及其制造方法 | |
KR20220154545A (ko) | 액체 금속을 포함하는 이방성 도전 필름, 그 제조방법 및 이를 이용한 표시장치 | |
KR100724720B1 (ko) | 도전성 접착제와 이 도전성 접착제를 이용한 단자간의 접속 방법 | |
JPH04292803A (ja) | 異方導電性フィルム | |
JP4542842B2 (ja) | 電極間接続構造 | |
JP4479582B2 (ja) | 電子部品実装体の製造方法 | |
JPS6386322A (ja) | 導電異方性接着剤シ−ト | |
JP2895569B2 (ja) | 電気的接続部材および電気回路部材 | |
JPH05290946A (ja) | 電子部品実装方法 | |
JP2003188212A (ja) | 半導体装置及びその製造方法 | |
JP2895570B2 (ja) | 電気的接続部材および電気回路部材 | |
JP2895568B2 (ja) | 電気回路部材 | |
JP2004127612A (ja) | 導電性微粒子、電極端子の相互接続方法及び導電接続構造体 | |
JP2009032948A (ja) | Icチップ及びicチップの実装方法 | |
JPH0430532A (ja) | 突起状電極バンプの構造及びその製法 | |
KR20010069358A (ko) | 공정합금계의 이방성 전도필름을 이용한 반도체 칩본딩공정 및 그 제조방법 | |
JPH10125720A (ja) | 半導体集積回路装置およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20892531 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20892531 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 16/01/2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20892531 Country of ref document: EP Kind code of ref document: A1 |